ABL1 and neoplasm: Recent reports have revealed that inhibition of the ABL kinases can decrease tumor outgrowth and impair metastatic spread, indicating the potential use of ABL kinase inhibitors for the treatment of some solid tumors with activated ABL kinases [2, 4–6, 10, 11, 17, 19–22].